Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia-Reference-Cited by-同舟云学术

Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

Published:2017-08-27 Issue:7 Volume:22 Page:1436-1458
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Jo Helen E.¹²^ORCID,Troy Lauren K.¹²,Keir Gregory³,Chambers Daniel C.⁴,Holland Anne⁵,Goh Nicole⁴⁶,Wilsher Margaret⁷,de Boer Sally⁷,Moodley Yuben⁸,Grainge Christopher⁹,Whitford Helen¹⁰,Chapman Sally¹¹,Reynolds Paul N.¹¹,Glaspole Ian¹⁰^ORCID,Beatson David¹²,Jones Leonie⁹,Hopkins Peter⁴,Corte Tamera J.¹²

Affiliation:

1. Department of Respiratory Medicine; Royal Prince Alfred Hospital; Sydney NSW Australia

2. Faculty of Medicine, University of Sydney; Sydney NSW Australia

3. Department of Respiratory Medicine, Princess Alexandra Hospital; Brisbane QLD Australia

4. Department of Respiratory Medicine, The Prince Charles Hospital; Brisbane QLD Australia

5. Department of Physiotherapy, The Alfred Hospital; Melbourne VIC Australia

6. Department of Respiratory Medicine; Austin Hospital; Melbourne VIC Australia

7. Department of Respiratory Medicine; Auckland District Health Board; Auckland New Zealand

8. Department of Respiratory Medicine; Fiona Stanley Hospital; Perth WA Australia

9. Department of Respiratory Medicine; John Hunter Hospital; Newcastle NSW Australia

10. Department of Respiratory Medicine, The Alfred Hospital; Melbourne VIC Australia

11. Department of Respiratory Medicine; Royal Adelaide Hospital; Adelaide SA Australia

12. Patient Advocate; Auckland New Zealand

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13146/fullpdf

Reference188 articles.

1. Raghu G Collard HR Egan JJ Martinez FJ Behr J Brown KK Colby TV Cordier JF Flaherty KR Lasky JA et al ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med 2011 183:

2. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature;Nalysnyk;Eur. Respir. Rev.,2012

3. Clinical course and prediction of survival in idiopathic pulmonary fibrosis;Ley;Am. J. Respir. Crit. Care Med.,2011

4. Raghu G Rochwerg B Zhang Y Garcia CA Azuma A Behr J Brozek JL Collard HR Cunningham W Homma S et al American Thoracic Society European Respiratory Society Japanese Respiratory Society Latin American Thoracic Association Am. J. Respir. Crit. Care Med 2015 192:

5. Idiopathic pulmonary fibrosis and the elderly: diagnosis and management considerations;Jo;Drugs Aging,2016

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of pulmonary rehabilitation on all-cause mortality in patients with chronic respiratory disease: A retrospective cohort study in an Australian teaching hospital.;2024-08-16

2. Comparison of the safety profiles for pirfenidone and nintedanib: a disproportionality analysis of the US food and drug administration adverse event reporting system;Frontiers in Pharmacology;2024-05-27

3. Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision;Respirology;2024-01-11

4. Pulmonary fibrosis treatment in children – What have we learnt from studies in adults?;Paediatric Respiratory Reviews;2023-12

5. Exploring the Role of Biomarkers Associated with Alveolar Damage and Dysfunction in Idiopathic Pulmonary Fibrosis—A Systematic Review;Journal of Personalized Medicine;2023-11-14